Literature DB >> 518082

Oral neomycin dosage schedules for suppression of ammonia production by bowel flora.

B Suh, J L Stephens, C M Kunin.   

Abstract

To better define a minimal but optimal dose of oral neomycin to suppress ammonia production by bowel flora, several dosage regimens were examined in normal healthy volunteers. Fecal urease activity was quantitatively determined and was used as an indirect measure of intrinsic ammonia production by bowel flora. Large doses of neomycin were found to exert inhibition of fecal urease for many days. There was considerable variation in enzymatic activity among subjects even after adjustments were made for protein content of the stool. Depending on the dose, there was a 1- to 3-day lag in neomycin effect on stool urease activity and several days of continued effect. The most effective regimen of those studied was a loading dose of 6 g of neomycin given in three divided doses on day 1, followed by 1 g twice daily.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 518082      PMCID: PMC352892          DOI: 10.1128/AAC.16.4.519

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Intestinal microflora in patients with alcoholic cirrhosis: urea-splitting bacteria and neomycin resistance.

Authors:  D Lai; S L Gorbach; R Levitan
Journal:  Gastroenterology       Date:  1972-02       Impact factor: 22.682

2.  Deafness following oral use of neomycin.

Authors:  V V Kalbian
Journal:  South Med J       Date:  1972-04       Impact factor: 0.954

3.  Gonococcal arthritis in children.

Authors:  C W Fink
Journal:  JAMA       Date:  1965-10-18       Impact factor: 56.272

4.  Morphologic alterations associated with neomycin induced malabsorption.

Authors:  W O Dobbins; B A Herrero; C M Mansbach
Journal:  Am J Med Sci       Date:  1968-01       Impact factor: 2.378

5.  Intrapleural neomycin causing ototoxicity.

Authors:  M Myerson; H F Knight; A J Gambarini; T L Curran
Journal:  Ann Thorac Surg       Date:  1970-05       Impact factor: 4.330

6.  Ammonia production in the human colon. Effects of cleansing, neomycin and acetohydroxamic acid.

Authors:  E Wolpert; S F Phillips; W H Summerskill
Journal:  N Engl J Med       Date:  1970-07-23       Impact factor: 91.245

7.  Deafness complicating antibiotic therapy of hepatic encephalopathy.

Authors:  D P Berk; T Chalmers
Journal:  Ann Intern Med       Date:  1970-09       Impact factor: 25.391

8.  Brief recording: deafness after topical neomycin wound irrigation.

Authors:  D R Kelly; E R Nilo; R B Berggren
Journal:  N Engl J Med       Date:  1969-06-12       Impact factor: 91.245

9.  Neomycin absorption in man. Studies of oral and enema administration and effect of intestinal ulceration.

Authors:  K J Breen; R E Bryant; J D Levinson; S Schenker
Journal:  Ann Intern Med       Date:  1972-02       Impact factor: 25.391

10.  Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.

Authors:  H O Conn; C M Leevy; Z R Vlahcevic; J B Rodgers; W C Maddrey; L Seeff; L L Levy
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.